A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function
NCT03739970 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2018-11-14
Summary
This study is a 8-week, randomized, double-blind, placebo-controlled clinical trial of Silk Peptide for the evaluation of efficacy on immune function enhancement.
Conditions
- Normal Healthy Subjects
Interventions
- DIETARY_SUPPLEMENT
-
Investigational Product (Silk Peptide)
* Ingredient: Silk Peptide * Type: Yellow granule stick * Storage: Room temperature * Weight: Silk Peptide 9g/day * Directions: with water before breakfast and dinner, 9g/day (4.5g×2times/day) * Duration of use: 8 weeks
- DIETARY_SUPPLEMENT
-
Control Group - Placebo Product
* Ingredient: Microcrystalline Cellulose * Type: Yellow granule stick * Storage: Room temperature * Weight: Silk Peptide 0g/day * Directions: with water before breakfast and dinner, 9g/day (4.5g×2times/day) * Duration of use: 8 weeks
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Principal Investigators
-
JONGHO LEE, Ph.D. · Yonsei University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-15
- Primary Completion
- 2019-01-29
- Completion
- 2019-02-28
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)
NCT03859141 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
NCT06342349 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Oral Supplements for Influenza Vaccine Response
NCT06827873 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
NCT03285997 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years
NCT03344029 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of an Oral Vaccine to Prevent Seasonal Influenza
NCT01688297 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity
NCT01896154 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza
NCT03903718 ·Status: WITHDRAWN ·Phase: PHASE2
-
Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza
NCT01719874 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents
NCT02621177 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain
NCT02423577 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trials of Quadrivalent Influenza Vaccine
NCT06824519 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
NCT06049927 ·Status: COMPLETED ·Phase: PHASE3
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China
NCT02228980 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine
NCT03755427 ·Status: COMPLETED ·Phase: PHASE2
-
B-cell Immunity to Influenza (SLVP017)- Year 1, 2009
NCT02133781 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old
NCT01355172 ·Status: COMPLETED ·Phase: PHASE4
-
Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults
NCT03814720 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of A Quadrivalent Influenza Vaccine
NCT03744104 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults
NCT02768805 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months
NCT03020628 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Drinking Fermented Milk on Immune Response
NCT02909842 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Double-blind, Parallel Phase III Study
NCT02352584 ·Status: COMPLETED ·Phase: PHASE3